Sort
23,748 grants matching “melanoma”
Interactions of ES Cells with 3D Biomaterials
$384,199Krishnendu Roy · University Of Texas At Austin · R01 · FY2009 · EB
Mechanism of Retinal Damage in Autoimmune Retinopathy
$384,170Oregon Health And Science University · R01 · FY2005 · EY
The Fibrosis-Lymphedema Continuum in Head and Neck Cancer
$384,109Sheila H Ridner · Vanderbilt University · R01 · FY2013 · CA
Role of gangliosides in tumor progression
$384,052Stephan Ladisch · Children'S Research Institute · R01 · FY2010 · CA
Role of gangliosides in tumor progression
$384,052Stephan Ladisch · Children'S Research Institute · R01 · FY2009 · CA
Comprehensive minimal residual disease tracking in cancer
$383,912G. Mike Makrigiorgos · Dana-Farber Cancer Inst · R01 · FY2018 · CA
Engineering Nanomaterials to Prime Immunity
$383,908James J. Moon · University Of Michigan At Ann Arbor · R01 · FY2019 · CA
Functional Analysis of the BAP1 Metastasis Suppressor Gene in Uveal Melanoma
$383,875Frank J. Rauscher · Wistar Institute · R01 · FY2015 · CA
Promotion of tumor invasion and pseudosenescence by the aging microenvironment
$383,875Ashani T Weeraratna · Wistar Institute · R01 · FY2014 · CA
Promotion of tumor invasion and pseudosenescence by the aging microenvironment
$383,875Ashani T Weeraratna · Wistar Institute · R01 · FY2015 · CA
Modulation of Anti-Tumor Immunity by Inhibitory Receptors
$383,814Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · P01 · FY2016 · AI
Novel biosynthetic pathway for secosteroids and the skin
$383,809Andrzej T Slominski · University Of Tennessee Health Sci Ctr · R01 · FY2007 · AR
A Nuclear Receptor COUP-TFII in Vascular Function: Angiogenesis and Tumoirgenesis
$383,750Sophia Y Tsai · Baylor College Of Medicine · R01 · FY2010 · HL
A Nuclear Receptor COUP-TFII in Vascular Function: Angiogenesis and Tumoirgenesis
$383,750Sophia Y Tsai · Baylor College Of Medicine · R01 · FY2009 · HL
A Nuclear Receptor COUP-TFII in Vascular Function: Angiogenesis and Tumoirgenesis
$383,750Sophia Y Tsai · Baylor College Of Medicine · R01 · FY2011 · HL
DEVELOPMENT OF GENOMICS BASED PERSONALIZED CANCER IMMUNOTHERAPY
$383,713Robert David Schreiber · Washington University · R01 · FY2018 · CA
Non-invasive Transcranial Histotripsy Treatment in a Murine Primary Malignant Brain Tumor Model
$383,701Zhen Xu · University Of Michigan At Ann Arbor · R21 · FY2021 · CA
New methods for structural variation analysis of rearranged cancer genomes using
$383,639Mikhail Kolmogorov · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Complex rearrangement detection in cancer genomes using long reads
$383,639Mikhail Kolmogorov · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Role of melanoma-PD-1 in cancer progression
$383,636Tobias Schatton · Brigham And Women'S Hospital · R01 · FY2019 · CA
Arginine deiminase as an Anti-Cancer Therapy
$383,600Phoenix Pharmacologics, Inc. · R44 · FY2001 · CA
Targeting antigen presentation to improve immunotherapy responses in breast cancer
$383,600Justin M Balko · Vanderbilt University Medical Center · P50 · FY2021 · CA
PROTEAN-CR: Proteomics Toolkit for Ensemble Analysis in Cancer Research
$383,598Lydia E. Kavraki · Rice University · U01 · FY2023 · CA
MicroRNA-Based Detection of Barriers to Melanoma Progression
$383,592Robert Laird Judson-Torres · University Of California, San Francisco · DP5 · FY2014 · OD
Identification of T Cell-Defined Antigens in Ovarian Cancer
$383,582Cassian Yee · Fred Hutchinson Cancer Research Center · R33 · FY2009 · CA